Investor Teach In

RNS Number : 5206F
OptiBiotix Health PLC
23 February 2015
 

Optibiotix Health Plc

(the "Company" or the "Group")

 

Investor Teach-In

 

OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces it will be holding a teach-in for investors and analysts on Wednesday, 18th March 2015.

The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 4.30pm.

A presentation will be given founder & CEO of OptiBiotix, Stephen O'Hara, for approximately one hour. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. This will be followed by light refreshments and an opportunity to network.

To register for the event, please email optibiotix@walbrookpr.com or call the Walbrook PR team below.

 

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

 

 

Cairn Financial Advisers LLP

Tel: 020 7148 7900

Liam Murray / Avi Robinson

 

 

 

 

Hybridan LLP (Joint Broker)

Claire Louise Noyce

 

 

Tel: 020 3713 4581

Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Lucy Williams / Duncan Vasey

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFVRFLIIFIE
UK 100

Latest directors dealings